Vanderbilt University Medical Center, Clinical Trials Center Investigational Drug Services is a clinical research site located in Nashville, Tennessee, United States 37212.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Vanderbilt University Medical Center, Clinical Trials Center Investigational Drug Services has participated in 1 clinical trials.
Therapeutic areas: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University Medical Center, Clinical Trials Center Investigational Drug Services has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University Medical Center, Clinical Trials Center Investigational Drug Services has 1 clinical trials on record. Their work covers Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome.
Vanderbilt University Medical Center, Clinical Trials Center Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.